Drug intelligence / Profile preview

bolandiol

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intramuscular
01

Overview

Bolandiol is a synthetic anabolic-androgenic steroid (AAS) that was never marketed in its base form, though its dipropionate ester derivative has been marketed. It is unique among AASs for possessing not only androgenic but also estrogenic and progestogenic activity. Bolandiol acts as an agonist at the androgen receptor (AR), estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), progesterone receptor A (PR-A), and progesterone receptor B (PR-B), but with lower potency compared to natural ligands such as testosterone or estradiol. In animal studies, it increases lean body mass and bone mineral density while exhibiting tissue selectivity—stimulating muscle growth comparably to testosterone but with minimal effect on sex accessory glands like the prostate. This profile suggests potential use as a "prostate-sparing" androgen or male contraceptive. Bolandiol suppresses gonadotropins and endogenous testosterone production, is considered a metabolic precursor to nandrolone, and has been used illicitly as a performance-enhancing supplement by athletes; it is banned by the World Anti-Doping Agency[1][3][4][5][6].

Other names
bolandiol
02

Targets

ESR1 (ERα)RB1 (Retinoblastoma-associated Protein)PR-A (Progesterone Receptor A)ESR2 (ERβ)AR (Adrenergic receptors)

Beyond the preview

Go deeper on bolandiol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bolandiol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call